WestEnd Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
Other funds holding LH
RRAM
JIC
BCWM
AAM
DIA
SFA
WCM
HPCM
MCM
ET
WestEnd Advisors's LH Position: Q2 2026 in Review
WestEnd Advisors held its Labcorp (LH) position steady in Q2 2026 at 3 shares worth $840. The position accounts for ﹤0.01% of the portfolio, ranked #296.
WestEnd Advisors first reported a position in LH in Q4 2021 and has held it in 16 quarters since. The position peaked at $861 in Q3 2025. 265 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- WestEnd Advisors held 3 shares of Labcorp worth $840 as of Q2 2026.
- WestEnd Advisors left its Labcorp share count unchanged in Q2 2026.
- Labcorp made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #296 holding.
- WestEnd Advisors first reported a position in Labcorp in Q4 2021 and has held it in 16 quarters since.
- WestEnd Advisors's Labcorp position peaked at $861 in Q3 2025.
- 265 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.